Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2-Bromoergocryptine Mesylate

Known as: Bromocriptine Mesylate, 2-Bromoergocryptine Mesylate [Chemical/Ingredient], Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)- 
The mesylate salt of bromocriptine, a semisynthetic ergot alkaloid with dopaminergic, antidyskinetic, and antiprolactinemic activities. Bromocriptine… Expand
National Institutes of Health

Related topics

Related topics

22 relations
AcromegalyAmenorrheaBromocriptineBromocriptine 0.8 MG Oral Tablet [Cycloset]
Expand

Narrower (2)

CyclosetParlodel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
BACKGROUND Patients with Parkinson disease (PD) treated with the nonergot dopamine agonists pramipexole dihydrochloride and… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
2004
Highly Cited
2004
The Chemistry of Peptide Ergot Alkaloids. Part 1. Classification and Chemistry of Ergot Peptides
Ergot alkaloids is a group of natural biologically active compounds belonging, according to the general alkaloid classification… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Review
1998
Review
1998
Management of Pituitary Tumors
Secreting and nonsecreting pituitary adenomas account for 10% of all intracranial tumors. Because most of these adenomas are… Expand
Highly Cited
1996
Highly Cited
1996
Gelatin microspheres: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties.
The aim of this paper was to investigate the influence of preparation parameters on gelatin microspheres production, chemico… Expand
Highly Cited
1993
Highly Cited
1993
Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases.
Restless legs syndrome (RLS) is a common neurosensorimotor disorder that presents with paresthesias, sleep disturbances and, in… Expand
Highly Cited
1987
Highly Cited
1987
Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.
Amantadine hydrochloride and bromocriptine mesylate were compared on a double-blind basis for withdrawal from cocaine dependence… Expand
Highly Cited
1983
Highly Cited
1983
Neuroleptic malignant syndrome. Successful treatment with bromocriptine.
THE NEUROLEPTIC malignant syndrome (NMS) is characterized by severe extrapyramidal dysfunction, hyperthermia, and autonomic… Expand
Highly Cited
1983
Highly Cited
1983
Management of a case of neuroleptic malignant syndrome with bromocriptine.
Neuroleptic malignant syndrome, a rare but potentially fatal side effect of antipsychotic medications, has often proven… Expand
Highly Cited
1982
Highly Cited
1982
Surveillance of bromocriptine in pregnancy.
Information was collected on the outcome of 1,410 pregnancies in 1,335 women to whom bromocriptine mesylate (Parlodel) had been… Expand
1982
1982
Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
The effects of hypophysectomy and prolactin-suppressing drugs on the growth of mammary tumors induced in Sprague-Dawley rats by N… Expand
  • table 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE